Bill Gates’ is about to mint millionaires (again) with Stargate.

This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrough so advanced, it’s going to make ChatGPT look like VHS. But what’s even more unbelievable? I believe it’ll make Nvidia’s meteoric rise look like a backyard bottle rocket.

Click here and I’ll tell you everything you need to know.

Mark Kroll Biography and Net Worth

Director of Axon Enterprise

Mark W. Kroll Ph.D., FACC. Dr. Kroll retired from St. Jude Medical Inc. in July 2005, where he held various executive level positions since 1995, most recently as Senior Vice President and Chief Technology Officer, Cardiac Rhythm Management Division. Dr. Kroll holds a B.S. degree in Mathematics and a M.S. degree and a Ph.D. degree in Electrical Engineering from the University of Minnesota and a M.B.A. degree from the University of St. Thomas. He has over 340 issued US patents and is a Fellow of the: American College of Cardiology, Heart Rhythm Society, Institute of Electronics and Electrical Engineering, and the American Institute for Medicine and Biology in Engineering. Dr. Kroll is also a director of Haemonetics Corporation.

What is Mark W. Kroll's net worth?: The estimated net worth of Mark W. Kroll is at least $6.19 million as of March 7th, 2023. Dr. Kroll owns 10,142 shares of Axon Enterprise stock worth more than $6,188,648 as of November 19th. This net worth estimate does not reflect any other assets that Dr. Kroll may own. Learn More about Mark W. Kroll's net worth.
How do I contact Mark W. Kroll?: The corporate mailing address for Dr. Kroll and other Axon Enterprise executives is 20-22 BEDFORD ROW, LONDON X0, WC1R 4JS. Axon Enterprise can also be reached via phone at (480) 991-0797 and via email at [email protected]. Learn More on Mark W. Kroll's contact information.
Has Mark W. Kroll been buying or selling shares of Axon Enterprise?: Mark W. Kroll has not been actively trading shares of Axon Enterprise during the last quarter. Most recently, Mark W. Kroll sold 3,549 shares of the business's stock in a transaction on Tuesday, March 7th. The shares were sold at an average price of $220.73, for a transaction totalling $783,370.77. Following the completion of the sale, the director now directly owns 10,142 shares of the company's stock, valued at $2,238,643.66. Learn More on Mark W. Kroll's trading history.
Who are Axon Enterprise's active insiders?: Axon Enterprise's insider roster includes Jawad Ahsan (CFO), Brittany Bagley (CFO), Adriane Brown (Director), Julie Cullivan (Director), Michael Garnreiter (Director), Joshua Isner (CRO), Caitlin Kalinowski (Director), Mark Kroll (Director), Jeffrey Kunins (Insider), Luke Larson (President), Matthew McBrady (Director), Hadi Partovi (Director), Patrick Smith (CEO), and Jeri Williams (Director). Learn More on Axon Enterprise's active insiders.
Are insiders buying or selling shares of Axon Enterprise?: In the last year, insiders at the biotechnology company sold shares 29 times. They sold a total of 546,629 shares worth more than $200,792,524.13. The most recent insider tranaction occured on November, 12th when President Joshua Isner sold 20,000 shares worth more than $12,123,000.00. Insiders at Axon Enterprise own 5.7% of the company. Learn More about insider trades at Axon Enterprise.
Information on this page was last updated on 11/12/2024.

Mark W. Kroll Insider Trading History at Axon Enterprise

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
3/7/2023	Sell	3,549	$220.73	$783,370.77	10,142
6/8/2022	Sell	3,159	$102.82	$324,808.38	13,691

Mark W. Kroll Buying and Selling Activity at Axon Enterprise

Axon Enterprise Company Overview

Axon Enterprise, Inc. develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence. Its products include axon officer safety plan; taser 10, taser7, taser X26P, taser X2, taser 7 CQ, and civilian series; cameras, such as axon body, axon flex, axon fleet, axon air, axon signal sidearm, axon signal vehicle, axon interview, and axon interview portable kit; software, including axon records, evidence, standards, commander, performance, auto-transcribe, justice, investigate, respond, and justice, my90, and redaction assistant; mobile applications, and training services, as well as hardware extended warranties; and Axon docks, cartridges, and batteries. The company sells its products through its direct sales, distribution partners, online store, and third-party resellers. Axon Enterprise, Inc. has a strategic partnership with Fusus, Inc. to expand bility to aggregate live video, data, and sensor feeds. It serves law enforcement, federal, correction, fire, EMS, campus, justice healthcare, retail, private security, and personal safety industries. The company was formerly known as TASER International, Inc. and changed its name to Axon Enterprise, Inc. in April 2017. Axon Enterprise, Inc. was incorporated in 1993 and is headquartered in Scottsdale, Arizona.

Today's Range

Now: $610.20

$598.01

$618.07

50 Day Range

MA: $448.52

$361.71

$616.14

2 Week Range

Now: $610.20

$224.16

$624.84

Volume

979,345 shs

Average Volume

553,311 shs

Market Capitalization

$46.53 billion

P/E Ratio

157.67

Dividend Yield

N/A

Beta

0.94